This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kirby, M. Search for Related Content Social Bookmarking                         What's this?

Painful diabetic neuropathy — current understanding and management for the primary care team

The Surgery, Nevells Road, Letchworth, SG6 4TS, UK, kirbym{at}globalnet.co.uk

Primary care has an increasing role in the diagnosis and treatment of painful diabetic neuropathy (PDN), and early accurate diagnosis and intervention can greatly improve the prognosis. With the incidence of diabetes predicted to increase dramatically, the number of patients with PDN is set to soar. PDN can have a serious impact on quality of life, leading to severe depression and even suicide. The evolution of a schematic approach to the diagnosis and treatment of PDN can offer new hope to many patients. This review focuses on PDN and current treatment strategies. Many leading pain clinics have adopted a multidisciplinary approach to the pharmacological and non-pharmacological management of PDN.

Key Words: painful • diabetic • neuropathy • primary health care team • management.

References

• Amos AF, McCarty DJ, Zimmet P. The rising global burden of Diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14:S7-S85.[CrossRef][Web of Science]
• Hughes RA Peripheral neuropathy. BMJ 2002;324:466-9.[Free Full Text]
• Vinik AI, Park TS, Stansberry KB, Pittenger GL Diabetic Neuropathies. Diabetologia 2000;43:957-73.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Young MJ, Boulton AJ, MacLeod AF et al. A multicentre study of the prevalence of peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes. Lancet 1998; 352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dyck PJ, Kratz KM, Karnes JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24.[Abstract/Free Full Text]
• Tesfaye S., Stevens LK, Stephenson JM et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39: 1377-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chan AW, MacFarlane IA, Bowsher DR et al. Chronic pain in patients with diabetes mellitus: comparison with non-diabetic population. The Pain Clinic 1990;3:147-59.
• Zeigler D., Greies AF, Spooler M. et al. The epidemiology of diabetic neuropathy. The J Diab Complic 1992;6:49-57.[CrossRef]
• Consensus Statement Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes 1988;37:1000-04.[Web of Science][Medline] [Order article via Infotrieve]
• Greene DA, Stevens MJ, Feldman EL Diabetic neuropathy: scope of the syndrome. Am J Med 1999;107:S2-7.[Medline] [Order article via Infotrieve]
• Thomas PK Metabolic neuropathy. J R Coll Physicians Lond 1973;7:154-60.[Medline] [Order article via Infotrieve]
• Levitt NS, Stansberry KB, Wychanck S., Vinik AI Natural progression of autonomic neuropathy and autonomic function test in a cohort of IDDM. Diabetes Care 1996;19: 751-4.[Abstract]
• Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol 1996;55: 1181-93.[Web of Science][Medline] [Order article via Infotrieve]
• Thomas PK Monitoring the natural history and results of therapeutic intervention in diabetic neuropathy: clinical measures. Electroencephalog. Clin Neurophysicol 1999;50:521-4.
• Gureje O., Von Korff M., Simon GE, Gater R. Persistent pain and well-being: a World Health Organisation Study in primary care. JAMA 1998;280:147-51.[Abstract/Free Full Text]
• Ellenberg N. Diabetic neuropathic cachexia. Diabetes 1974;23:418-23.[Web of Science][Medline] [Order article via Infotrieve]
• Tesfaye S., Malik R., Harris N. et al. Arteriovenious shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996;39:329-35.[Web of Science][Medline] [Order article via Infotrieve]
• Young MJ, Breddy JL, Boulton AJM. The prediction of diabetic foot ulceration using vibration perception thresholds: a perception study. Diabetes Care 1994;17:557-60.[Abstract]
• Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001;92:147-57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277-99.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Scott J., Huskisson EC Graphic representation of pain. Pain 1976;2:175-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Galer BS, Jensen M. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathy pain scale. Neurology 1997;48:332-9.[Abstract/Free Full Text]
• Ziegler D., Hanefeild M., Ruhnau KJ et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alphalipoic acid. A three week multicentre randomised controlled trial (ALADIN study). Diabetologia 1995;38:1425-33.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dyck PJ Detection, characterisation, and staging of polyneuropathy. Muscle Nerve 1988;11:21-32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vileikyte L., Bundy C., Tomenson B., Walsh B., Boulton AJM. Neuropathy-specific quality of life measure: construction of scales and preliminary tests of reliability and validity. Diabetes 1998;47:A44.
• Bradley C., Todd C., Gorton T., Symonds E., Martin A., Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999;8:79-91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Max MB, Culnane M., Schafer SC et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-96.[Abstract/Free Full Text]
• UK Prospective Diabetes Study Group (UKPDS 38). Tight blood pressure control and risk of macro and microvascular complications in type 2 diabetes. BMJ 1998;317: 703-13.[Abstract/Free Full Text]
• Backonja M., Beydoun A., Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-6.[Abstract/Free Full Text]
• Spruce MC, Potter J., Coppini DV The pathogenesis and management of painful diabetic neuropathy: a review. Diabet Med 2003; 20:88-98.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dejgard A., Petersen P., Kastrup J. Mexiletine for the treatment of chronic painful diabetic neuropathy. Lancet 1988:1(8575-6):9-11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Harati Y., Gooch C., Swenson M. et al. Maintenance of the long-term effectiveness of Tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 2000;14:65-70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Abuaesha BB, Costanzi JB, Boulton AJM. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 1998;39:115-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 2, 138-144 (2003)
DOI: 10.1177/14746514030030021001


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kirby, M. Search for Related Content Social Bookmarking                         What's this?